ArticleJournal of the National Comprehensive Cancer Network : JNCCN2026
Targeting BCMA in Plasmablastic Lymphoma With Teclistamab: A Case Study of Three Patients.
Joseph M Cannova et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.